335 related articles for article (PubMed ID: 29572021)
1. A novel tissue treatment to reduce mineralization of bovine pericardial heart valves.
Meuris B; De Praetere H; Strasly M; Trabucco P; Lai JC; Verbrugghe P; Herijgers P
J Thorac Cardiovasc Surg; 2018 Jul; 156(1):197-206. PubMed ID: 29572021
[TBL] [Abstract][Full Text] [Related]
2. The Immune Responses and Calcification of Bioprostheses in the α1,3-Galactosyltransferase Knockout Mouse.
Sung Jeong W; Jin Kim Y; Lim HG; Jung S; Ryul Lee J
J Heart Valve Dis; 2016 Mar; 25(2):253-261. PubMed ID: 27989076
[TBL] [Abstract][Full Text] [Related]
3. Advanced Integrity Preservation Technology Reduces Bioprosthesis Calcification While Preserving Performance and Safety.
De La Fuente AB; Wright GA; Olin JM; Duhay FG; Kapelak B; Bochenek M; Bartus K; Sadowski J
J Heart Valve Dis; 2015 Jan; 24(1):101-9. PubMed ID: 26182627
[TBL] [Abstract][Full Text] [Related]
4. Octanediol treatment of glutaraldehyde fixed bovine pericardium: evidence of anticalcification efficacy in the subcutaneous rat model.
Pettenazzo E; Valente M; Thiene G
Eur J Cardiothorac Surg; 2008 Aug; 34(2):418-22. PubMed ID: 18550382
[TBL] [Abstract][Full Text] [Related]
5. Fixation of Bovine Pericardium-Based Tissue Biomaterial with Irreversible Chemistry Improves Biochemical and Biomechanical Properties.
Tam H; Zhang W; Infante D; Parchment N; Sacks M; Vyavahare N
J Cardiovasc Transl Res; 2017 Apr; 10(2):194-205. PubMed ID: 28213846
[TBL] [Abstract][Full Text] [Related]
6. A multi-step approach in anti-calcification of glutaraldehyde-preserved bovine pericardium.
Neethling WM; Hodge AJ; Clode P; Glancy R
J Cardiovasc Surg (Torino); 2006 Dec; 47(6):711-8. PubMed ID: 17043620
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of in vivo models for studying calcification behavior of commercially available bovine pericardium.
Quintero LJ; Lohre JM; Hernandez N; Meyer SC; McCarthy TJ; Lin DS; Shen SH
J Heart Valve Dis; 1998 May; 7(3):262-7. PubMed ID: 9651837
[TBL] [Abstract][Full Text] [Related]
8. Combined anti-calcification treatment of bovine pericardium with amino compounds and solvents.
Chang HW; Kim SH; Kim KH; Kim YJ
Interact Cardiovasc Thorac Surg; 2011 Jun; 12(6):903-7. PubMed ID: 21388989
[TBL] [Abstract][Full Text] [Related]
9. Feasibility evaluation of a new pericardial bioprosthesis with dye mediated photo-oxidized bovine pericardial tissue.
Bianco RW; Phillips R; Mrachek J; Witson J
J Heart Valve Dis; 1996 May; 5(3):317-22. PubMed ID: 8793684
[TBL] [Abstract][Full Text] [Related]
10. Rosuvastatin attenuates bioprosthetic heart valve calcification.
Lee S; Kim DH; Youn YN; Joo HC; Yoo KJ; Lee SH
J Thorac Cardiovasc Surg; 2019 Sep; 158(3):731-741.e1. PubMed ID: 30738596
[TBL] [Abstract][Full Text] [Related]
11. Anticalcification effect of a combination of decellularization, organic solvents and amino acid detoxification on glutaraldehyde-fixed xenopericardial heart valves in a large-animal long-term circulatory model.
Park CS; Kim YJ; Lee JR; Lim HG; Chang JE; Jeong S; Kwon N
Interact Cardiovasc Thorac Surg; 2017 Sep; 25(3):391-399. PubMed ID: 28505294
[TBL] [Abstract][Full Text] [Related]
12. Mitigation of calcification and cytotoxicity of a glutaraldehyde-preserved bovine pericardial matrix: improved biocompatibility after extended implantation in the subcutaneous rat model.
Neethling WM; Glancy R; Hodge AJ
J Heart Valve Dis; 2010 Nov; 19(6):778-85. PubMed ID: 21214104
[TBL] [Abstract][Full Text] [Related]
13. In vitro properties and performance of glutaraldehyde-crosslinked bovine pericardial bioprostheses treated with glutamic acid.
Braile MC; Carnevalli NC; Goissis G; Ramirez VA; Braile DM
Artif Organs; 2011 May; 35(5):497-501. PubMed ID: 21595718
[TBL] [Abstract][Full Text] [Related]
14. Comparison of early hemodynamic performance of 3 aortic valve bioprostheses.
Ugur M; Suri RM; Daly RC; Dearani JA; Park SJ; Joyce LD; Burkhart HM; Greason KL; Schaff HV
J Thorac Cardiovasc Surg; 2014 Nov; 148(5):1940-6. PubMed ID: 24530199
[TBL] [Abstract][Full Text] [Related]
15. A novel anti-calcification strategy of bovine pericardium using sodium bisulfite modification.
Zhou J; Jiang H; Wang D; Hu S
J Heart Valve Dis; 2009 Mar; 18(2):180-5; discussion 186. PubMed ID: 19455893
[TBL] [Abstract][Full Text] [Related]
16. Trilogy pericardial valve: hemodynamic performance and calcification in adolescent sheep.
Flameng W; Meuris B; De Visscher G; Cunanan C; Lane E; Verbeken E; Herijgers P; Herregods MC
Ann Thorac Surg; 2008 Feb; 85(2):587-92. PubMed ID: 18222270
[TBL] [Abstract][Full Text] [Related]
17. Prevention of calcification with TPEN in pericardial bioprosthetic heart valve material.
Döndaş HA; Yilmaz N; Cömelekoğlu U; Tamer L; Sucu N; Aytaçoğlu BN; Ozeren M; Köse N; Dikmengil M
Anadolu Kardiyol Derg; 2007 Dec; 7(4):365-70. PubMed ID: 18065330
[TBL] [Abstract][Full Text] [Related]
18. Anticalcification effects of decellularization, solvent, and detoxification treatment for genipin and glutaraldehyde fixation of bovine pericardium.
Lim HG; Kim SH; Choi SY; Kim YJ
Eur J Cardiothorac Surg; 2012 Feb; 41(2):383-90. PubMed ID: 21683607
[TBL] [Abstract][Full Text] [Related]
19. Nanocoating with titanium reduces iC3b- and granulocyte-activating immune response against glutaraldehyde-fixed bovine pericardium: a new technique to improve biologic heart valve prosthesis durability?
Guldner NW; Bastian F; Weigel G; Zimmermann H; Maleika M; Scharfschwerdt M; Rohde D; Sievers HH
J Thorac Cardiovasc Surg; 2012 May; 143(5):1152-9. PubMed ID: 22153860
[TBL] [Abstract][Full Text] [Related]
20. Heat treatment mitigates calcification of valvular bioprostheses.
Carpentier SM; Chen L; Shen M; Fornes P; Martinet B; Quintero LJ; Witzel TH; Carpentier AF
Ann Thorac Surg; 1998 Dec; 66(6 Suppl):S264-6. PubMed ID: 9930461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
